Dr. Carol Dahl is the executive director of The Lemelson Foundation. With a background in discovery sciences, innovation programs and global health and development, Dahl leads the Foundation’s work to use the power of invention to improve lives.
Prior to joining the foundation in July 2011, Dahl worked for the Bill and Melinda Gates Foundation in various roles, including founding director of the Global Health Discovery Program and as director of staff for the overall Global Health Program. During her tenure at the Gates Foundation, Dahl built the platform discovery innovation programs Grand Challenges in Global Health and Grand Challenges Explorations.
Previously, Dahl served as vice president for Strategic Partnerships at Biospect Inc. (now Pathworks Diagnostics). From 1990 to 2001, Dahl worked at the US National Institutes of Health (NIH) in several capacities, including founding director of the Office of Technology and Industrial Relations at the National Cancer Institute (NCI) and program director at the National Center for Human Genome Research. Throughout her tenure in government, Dahl received numerous awards for her work stimulating innovative technologies, including DNA sequencing technology, bioengineering, bioimaging, and nanotechnology, and contributing to the launch of critical genomics resources, such as the Tumor Gene Index.
She serves on the advisory committee of the US Agency for International Development (USAID) Global Development Lab, and on the executive committee of the Aspen Network of Development Entrepreneurs (ANDE).